Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials
Open Access
- 28 September 2022
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 108 (1) , 26-30
Abstract
Objective INGR1D (INvestigating Genetic Risk for type 1 Diabetes) was a type 1 diabetes (T1D) genetic screening study established to identify participants for a primary prevention trial (POInT, Primary Oral Insulin Trial). Methods The majority of participants were recruited by research midwives in antenatal clinics from 18 weeks’ gestation. Using the NHS Newborn Bloodspot Screening Programme (NBSP) infrastructure, participants enrolled in INGR1D had an extra sample taken from their day 5 bloodspot card sent for T1D genetic screening. Those at an increased risk of T1D were informed of the result, given education about T1D and the opportunity to take part in POInT. Results Between April 2018 and November 2020, 66% of women approached about INGR1D chose to participate. 15 660 babies were enrolled into INGR1D and 14 731 blood samples were processed. Of the processed samples, 157 (1%) had confirmed positive results, indicating an increased risk of T1D, of whom a third (n=49) enrolled into POInT (20 families were unable to participate in POInT due to COVID-19 lockdown restrictions). Conclusion The use of prospective consent to perform personalised genetic testing on samples obtained through the routine NBSP represents a novel mechanism for clinical genetic research in the UK and provides a model for further population-based genetic studies in the newborn.Keywords
All Related Versions
Funding Information
- Wellcome (107212/Z/15/Z, 203141/Z/16/Z)
- Leona M. and Harry B. Helmsley Charitable Trust (2018PG‐T1D022, 2018PG‐T1D026)
- Juvenile Diabetes Research Foundation (5-SRA-2015-130-A-N, 4-SRA-2017-473-A-N)
This publication has 34 references indexed in Scilit:
- Why is type 1 diabetes increasing?Journal of Molecular Endocrinology, 2013
- Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populationsDiabetologia, 2012
- Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic riskDiabetologia, 2012
- Type 1 Diabetes2010
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration studyThe Lancet, 2009
- The Environmental Determinants of Diabetes in the Young (TEDDY) StudyAnnals of the New York Academy of Sciences, 2008
- Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk lociNature Genetics, 2008
- Absolute Risk of Childhood-Onset Type 1 Diabetes Defined by Human Leukocyte Antigen Class II Genotype: A Population-Based Study in the United KingdomThe Journal of Clinical Endocrinology & Metabolism, 2004
- Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locusNature Genetics, 1997
- Secular Trends in Incidence of Childhood IDDM in 10 CountriesDiabetes, 1990